---
title: "Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease | INSM Stock News"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/280147174.md"
description: "Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease | INSM Stock News"
datetime: "2026-03-23T03:00:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280147174.md)
  - [en](https://longbridge.com/en/news/280147174.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280147174.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/280147174.md) | [繁體中文](https://longbridge.com/zh-HK/news/280147174.md)


# Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease | INSM Stock News

Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease | INSM Stock News

### 相关股票

- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [Invesco Dorsey Wright Healthcare Momentum ETF (PTH.US)](https://longbridge.com/zh-CN/quote/PTH.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [Direxion S&P Biotech Bull 3X (LABU.US)](https://longbridge.com/zh-CN/quote/LABU.US.md)
- [Insmed (INSM.US)](https://longbridge.com/zh-CN/quote/INSM.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md)

## 相关资讯与研究

- [Insmed Sees Rising Physician Adoption of Brinsupri, Morgan Stanley Says](https://longbridge.com/zh-CN/news/281049788.md)
- [Nordea Investment Management AB Makes New Investment in Insmed, Inc. $INSM](https://longbridge.com/zh-CN/news/280871422.md)
- [Insmed (INSM): ENCORE Phase 3 Success Expands MAC Lung Disease Opportunity and Underscores Arikayce Upside](https://longbridge.com/zh-CN/news/280194631.md)
- [Insmed Maps Aggressive 2026 As Newly Approved Lung Disease Drug Gains Traction, Pipeline Advances](https://longbridge.com/zh-CN/news/272101100.md)
- [Insmed Announces Strong 2025 Results and Pipeline Progress](https://longbridge.com/zh-CN/news/272077200.md)